Juntendo University Research: Light-activated Protein Treats Parkinson's Disease in a Fly Model

Thursday, February 13, 2020 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

TOKYO, Feb. 13, 2020 /PRNewswire/ -- A light-sensitive protein can restore mitochondria function in fruit flies bearing a gene mutation associated with Parkinson's disease and relieve its symptoms, report researchers at Juntendo University in the journal Communications Biology. The results provide a 'proof of concept' for the approach as a potential treatment for Parkinson's disease.

Related videosProfessor Imai describes this research https://youtu.be/WVE1fAw90aU

Parkinson's disease is estimated to affect 10 million worldwide, with a prevalence of almost 2 in every 100 among those aged 80 and over. Functional failure in the mitochondria – known as the power houses of cells – is thought to lead to the disease's many symptoms, which primarily impact mobility resulting in shaking, slowness and stiffness, but also include a number of physical, cognitive and psychological symptoms such as nerve pain, dizziness, dementia and depression. Yuzuru Imai and Nobutaka Hattori at Juntendo University and colleagues at the University of Shizuoka and Waseda University in Japan have now developed a light-activated protein, named mito-Delta-rhodopsin (mito-dR), that restores mitochondrion function in a fruit fly model of the disease.

Previous research has pointed towards mutations in the protein coding gene CHCHD2 as the cause of the disease, as well as identifying a number of cellular processes that the disease affects. In terms of energy generating processes, production of ATP – the energy currency in cells – is diminished and the generation of reactive oxygen species increases. Other changes include an accumulation of a-synuclein, a protein mostly found at the tips of neurons, a lack of buffering of the levels of Ca2+ ions, which transfer signals around the nervous system, and ultimately a loss of dopaminergic neurons.

As a model to study the disease, Imai, Hattori and colleagues used Drosophila where the fly's analogue for the CHCHD2 gene was made inoperative (knocked out). They found that decreased ATP production, increased reactive oxygen species, a-synuclein accumulation and loss of Ca2+-buffering, as well as neuron loss all resulted from the genetic modification.

Mitochondrial functions involve the interplay of complex reaction cycles, redox processes and electrochemical forces. In the hope of restoring the lost functions, the researchers examined the effects when the flies were treated with mitochondria designed to express a light-activated proton-transporter protein – Delta-rhodopsin. They found that with exposure to light the mitochondria functions were restored in the flies expressing this protein in cell mitochondria. They also noted the beneficial effects on mitochondrial functions of dopaminergic terminals, increased dopamine production, locomotor activity and flight behavior.

The same functions were not restored in controls expressing mito-dR designed not to respond to light, confirming that the action of the light-activated protein and not the light itself was responsible for the observed recoveries. The researchers conclude that the results provide a 'proof of concept' for a potential therapeutic strategy for Parkinson's disease.

Background

Redox reactions

Reactions that add oxygen atoms to a molecule are called oxidizing reactions and those that reduce the number of oxygen atoms are called reduction reactions. As an extension of their role in these reactions, the transfer of hydrogen ions (H+) and electrons are also described as oxidizing and reducing, or collectively redox, processes. 

Mitochondria and energy

Adenosine triphosphate (ATP) is the chemical responsible for capturing chemical energy from the breakdown of food so that it can be used to fuel the functions of cells throughout the body. Mitochondria produce ATP by oxidizing pyruvate and NADH, the main products of glucose. The process includes a series of reactions called the citric acid cycle. Pyruvate is actively transported across the inner mitochondrial membrane to the mitochondrial matrix where the citric cycle enzymes are found. The citric cycle also produces reduced cofactors that are a source of electrons in the electron transport train.

Small amounts of energy released in the transfer of chemicals that feed into the electron transport chain can be used to pump protons into the intermembrane space, which establishes an electrochemical gradient across the inner membrane. Electrons that prematurely reduce oxygen in this process can lead to reactive oxygen species and cause oxidative stress to the mitochondria, which is related to age-related mitochondrial decline. Conversely proton leak can lower the production of reactive oxygen species and is thought to occur as mitochondrial proton-motive force rises.

Mitochondria can also store Ca2+ ions. Regulating the concentration of these ions affects signal reactions important for signal transduction in the cell. The release of these ions can lead to calcium ion spikes and changes in the membrane potential. It can also trigger the release of neurotransmitters in nerve cells and hormones in endocrine cells.

Delta-rhodopsin

Delta-rhodopsin (dR) is a type of bacteria that thrives in high salt concentrations. It drives unidirectional transmembrane ion transport in response to light through isomerization – a rearrangement of the constituent atoms – of a form of vitamin A known as retinal.

In their control experiments the researchers replace two of the key residues involved in the isomerization with non-functional amino acids. So that the control dR although present was not activated by light.

Reference

Yuzuru Imai, Tsuyoshi Inoshita, Hongrui Meng, Kahori Shiba-Fukushima, Kiyotaka Y. Hara, Naoya Sawamura and Nobutaka Hattori. Light-driven activation of mitochondrial protonmotive force improves motor behaviors in a Drosophila model of Parkinson's disease. Communications Biology, December 2019.

DOI: 10.1038/s42003-019-0674-1

URL: https://doi.org/10.1038/s42003-019-0674-1 

Further information about Juntendo University

Mission Statement

The mission of Juntendo University is to strive for advances in society through education, research, and healthcare, guided by the motto "Jin – I exist as you exist" and the principle of "Fudan Zenshin - Continuously Moving Forward". The spirit of "Jin", which is the ideal of all those who gather at Juntendo University, entails being kind and considerate of others. The principle of "Fudan Zenshin" conveys the belief of the founders that education and research activities will only flourish in an environment of free competition. Our academic environment enables us to educate outstanding students to become healthcare professionals patients can believe in, scientists capable of innovative discoveries and inventions, and global citizens ready to serve society.

History of Juntendo University

Juntendo was originally founded in 1838 as a Dutch School of Medicine at a time when Western medical education was not yet embedded as a normal part of Japanese society. With the creation of Juntendo, the founders hoped to create a place where people could come together with the shared goal of helping society through the powers of medical education and practices. Their aspirations led to the establishment of Juntendo Hospital, the first private hospital in Japan. Through the years the institution's experience and perspective as an institution of higher education and a place of clinical practice has enabled Juntendo University to play an integral role in the shaping of Japanese medical education and practices. Along the way the focus of the institution has also expanded, now consisting of four undergraduate programs and three graduate programs, the university specializes in the fields of health and sports science and nursing health care and sciences, as well as medicine. Today, Juntendo University continues to pursue innovative approaches to international level education and research with the goal of applying the results to society.

Further informationJuntendo University2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421 JAPANE-mail:  release@juntendo.ac.jp Website: http://www.juntendo.ac.jp/english/ Research: https://www.juntendo.ac.jp/english/research.html

 

Cision View original content:http://www.prnewswire.com/news-releases/juntendo-university-research-light-activated-protein-treats-parkinsons-disease-in-a-fly-model-301004291.html

SOURCE Juntendo University



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store